Filing Flows › Health Care › HealthLynked (HLYK)
HealthLynked (HLYK) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 14, 2026 · HealthLynked (HLYK) Q2 2026 earnings results →
Q2 2026 Revenue down 58% year over year to $250K · 328¢ of every $1 of revenue lost · operating margin -215.7%
HealthLynked made $250K in Q2 2026 (-58% Y/Y): Patient service revenue, net $231K, Product revenue $12K, Subscription revenue $7K. Operating margin -215.7%, net loss $820K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 14, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $250K in Q2 2026, down 58% year over year and down 41% from the previous quarter. Patient service revenue, net was the largest line at 92% of revenue. Patient service revenue, net lost $342K year over year (down 60%), 100% of the total change.
Operating costs exceeded revenue by $539K, an operating margin of -215.7%. Total costs fell 23% while revenue fell 58%. The fastest-growing cost line was SG&A (+15%). The quarter ended with a net loss of $820K, narrower than the previous quarter's $1.6M loss.
Operating cash flow was −$350K. Non-cash charges added back $10K of depreciation and $88K of share-based compensation. Working capital and other items added $371K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 14, 2026 | $250K | -58% | -215.7% | −$820K | −$350K |
| Q1 2026 | 10-Q | May 15, 2026 | $423K | -45% | -165.5% | −$1.6M | −$222K |
| Q4 2025 | 10-K | Mar 31, 2026 | $310K | -50% | -171.2% | −$676K | −$419K |
| Q3 2025 | 10-Q | Nov 19, 2025 | $389K | -34% | -136.3% | −$852K | −$444K |
| Q2 2025 | 10-Q | Aug 14, 2025 | $592K | -26% | -73.5% | −$701K | −$418K |
| Q1 2025 | 10-Q | May 15, 2025 | $774K | -23% | -79.7% | −$1.1M | −$433K |
| Q4 2024 | 10-K | Mar 31, 2025 | $619K | -34% | -121.0% | −$1.2M | −$744K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Buys from
About HealthLynked
HealthLynked Corp. (the “Company,” “we,” “our,”) is a healthcare technology company incorporated in the State of Nevada on August 6, 2014. We operate across three primary divisions – Digital Healthcare, Health Services, and Medical Distribution – each dedicated to leveraging innovative solutions that enhance patient care, reduce costs, and generate long-term value for stockholders. Within our Digital Healthcare division, we develop and manage the HealthLynked Network, a robust, cloud-based platform that centralizes personal medical records and streamlines communication between patients and healthcare providers. Our platform integrates software-based decision-support tools (including AI-enabled features), on-demand telemedicine services, and concierge support, delivering a technology-enabled patient experience.
In its own words, from its 10-K, filed Mar 31, 2026.
HealthLynked against its Services-Offices & Clinics of Doctors of Medicine peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -58% against the peers' median -3%. Operating margin: -215.7% against the peers' median -12.9%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| HLYK HealthLynked | Q2 2026 | $250K | -58% | -215.7% |
| HIMS Hims & Hers Health | Q2 2026 | $753M | +38% | -12.9% |
| TDOC Teladoc Health | Q3 2026 | $605M | -3% | -4.6% |
| STLN Starling Oncology | Q3 2026 | $170M | +24% | -1.8% |
| SBC SBC Medical Group Holdings | Q2 2026 | $49.2M | +13% | 38.5% |
| LFMD LifeMD | Q2 2026 | $47.3M | -4% | -15.1% |
| AIRS Airsculpt Technologies | Q3 2026 | $31.9M | -9% | -13.0% |
| CDIX Cardiff Lexington | Q2 2026 | $2.2M | -23% | -25.2% |
Source: HealthLynked 10-Q on SEC EDGAR · CIK 1680139 · Services-Offices & Clinics of Doctors of Medicine
13F: who owns HLYK and who is buying
More on HLYK
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results